ESRC Centre for Society and Mental Health, Institute of Psychiatry, Psychology, and Neuroscience, King's College, London, UK.
National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.
Psychol Med. 2022 Oct;52(13):2641-2650. doi: 10.1017/S0033291720004705. Epub 2021 Feb 4.
The clinical course of psychotic disorders is highly variable. Typically, researchers have captured different course types using broad pre-defined categories. However, whether these adequately capture symptom trajectories of psychotic disorders has not been fully assessed. Using data from AESOP-10, we sought to identify classes of individuals with specific symptom trajectories over a 10-year follow-up using a data-driven approach.
AESOP-10 is a follow-up, at 10 years, of 532 incident cases with a first episode of psychosis initially identified in south-east London and Nottingham, UK. Using extensive information on fluctuations in the presence of psychotic symptoms, we fitted growth mixture models to identify latent trajectory classes that accounted for heterogeneity in the patterns of change in psychotic symptoms over time.
We had sufficient data on psychotic symptoms during the follow-up on 326 incident patients. A four-class quadratic growth mixture model identified four trajectories of psychotic symptoms: (1) remitting-improving (58.5%); (2) late decline (5.6%); (3) late improvement (5.4%); (4) persistent (30.6%). A persistent trajectory, compared with remitting-improving, was associated with gender (more men), black Caribbean ethnicity, low baseline education and high disadvantage, low premorbid IQ, a baseline diagnosis of non-affective psychosis and long DUP. Numbers were small, but there were indications that those with a late decline trajectory more closely resembled those with a persistent trajectory.
Our current approach to categorising the course of psychotic disorders may misclassify patients. This may confound efforts to elucidate the predictors of long-term course and related biomarkers.
精神病障碍的临床病程高度可变。通常,研究人员使用广泛的预先定义的类别来捕捉不同的病程类型。然而,这些类别是否充分捕捉到精神病障碍的症状轨迹尚未得到充分评估。利用 AESOP-10 中的数据,我们试图使用数据驱动的方法,在 10 年的随访中确定具有特定症状轨迹的个体类别。
AESOP-10 是对英国伦敦东南部和诺丁汉首次出现精神病发作的 532 例首发精神病患者进行的 10 年随访。使用关于精神病症状波动的大量信息,我们拟合了增长混合模型,以确定潜伏轨迹类别,这些类别解释了随时间变化的精神病症状变化模式的异质性。
我们在 326 例首发患者的随访中有足够的数据来描述精神病症状。一个四分类二次增长混合模型确定了四种精神病症状轨迹:(1)缓解改善型(58.5%);(2)晚期衰退型(5.6%);(3)晚期改善型(5.4%);(4)持续型(30.6%)。与缓解改善型相比,持续型与性别(更多男性)、加勒比黑人群体、基线教育水平低和劣势程度高、低学前智商、基线非情感性精神病诊断和长的病期有关。人数较少,但有迹象表明,晚期衰退轨迹的患者更类似于持续型的患者。
我们目前对精神病障碍病程进行分类的方法可能会错误分类患者。这可能会干扰对长期病程和相关生物标志物的预测因素的研究。